期刊文献+
共找到200篇文章
< 1 2 10 >
每页显示 20 50 100
Case Report and Clinical Management of a Case of Osteogenesis Imperfecta Detected in the Prenatal Period
1
作者 Amina Chaieb Oumayma Ben Rejeb +4 位作者 Samar Knaz Yasmine Ben Ali Syrine Chelly Safia Ernez Mouna Derouiche 《Open Journal of Obstetrics and Gynecology》 2024年第7期996-1002,共7页
Osteogenesis imperfecta is a hereditary disease characterized by bone fragility due to a defect in type I collagen synthesis. The diagnosis is typically suspected based on suggestive ultrasound findings and confirmed ... Osteogenesis imperfecta is a hereditary disease characterized by bone fragility due to a defect in type I collagen synthesis. The diagnosis is typically suspected based on suggestive ultrasound findings and confirmed through genetic studies. We present a case of osteogenesis imperfecta suspected during obstetrical ultrasound at 19 weeks’ gestation, which was later confirmed radiographically through computed tomography. Due to the severity of the condition, therapeutic termination of pregnancy was indicated. 展开更多
关键词 osteogenesis imperfecta Ultrasound Screening Antenatal Diagnosis
下载PDF
Classification of osteogenesis imperfecta:Importance for prophylaxis and genetic counseling
2
作者 Monica-Cristina Panzaru Andreea Florea +1 位作者 Lavinia Caba Eusebiu Vlad Gorduza 《World Journal of Clinical Cases》 SCIE 2023年第12期2604-2620,共17页
Osteogenesis imperfecta(OI)is a genetically heterogeneous monogenic disease characterized by decreased bone mass,bone fragility,and recurrent fractures.The phenotypic spectrum varies considerably ranging from prenatal... Osteogenesis imperfecta(OI)is a genetically heterogeneous monogenic disease characterized by decreased bone mass,bone fragility,and recurrent fractures.The phenotypic spectrum varies considerably ranging from prenatal fractures with lethal outcomes to mild forms with few fractures and normal stature.The basic mechanism is a collagen-related defect,not only in synthesis but also in folding,processing,bone mineralization,or osteoblast function.In recent years,great progress has been made in identifying new genes and molecular mechanisms underlying OI.In this context,the classification of OI has been revised several times and different types are used.The Sillence classification,based on clinical and radiological characteristics,is currently used as a grading of clinical severity.Based on the metabolic pathway,the functional classification allows identifying regulatory elements and targeting specific therapeutic approaches.Genetic classification has the advantage of identifying the inheritance pattern,an essential element for genetic counseling and prophylaxis.Although genotype-phenotype correlations may sometimes be challenging,genetic diagnosis allows a personalized management strategy,accurate family planning,and pregnancy management decisions including options for mode of delivery,or early antenatal OI treatment.Future research on molecular pathways and pathogenic variants involved could lead to the development of genotype-based therapeutic approaches.This narrative review summarizes our current understanding of genes,molecular mechanisms involved in OI,classifications,and their utility in prophylaxis. 展开更多
关键词 osteogenesis imperfecta HETEROGENEITY CLASSIFICATION Molecular mechanism Genetic counseling PROPHYLAXIS
下载PDF
Osteogenesis Imperfecta: One Disease, Two or More Faces: A Case Report
3
作者 Anjali-Larisha Chhiba Firdose Lambey Nakwa Kebashni Thandrayen 《Case Reports in Clinical Medicine》 2023年第2期52-60,共9页
Being such a rare condition in paediatrics, osteogenesis imperfecta (OI) is not a diagnosis which is made often. It is however, a diagnosis necessitating early diagnosis and timeous and effective management to improve... Being such a rare condition in paediatrics, osteogenesis imperfecta (OI) is not a diagnosis which is made often. It is however, a diagnosis necessitating early diagnosis and timeous and effective management to improve morbidity and increase the quality of life for our patients. We report two cases of osteogenesis imperfecta in this case report to highlight the different phenotypic presentations. Both of these patients are unique in their presentations and each case highlights the importance of a high clinical index of suspicion by the practitioner in making the diagnosis of osteogenesis imperfecta. The first case is a patient who was diagnosed with osteogenesis imperfecta on day one of life. She had disproportionate short stature, blue sclera, a small chest and bowing of her lower limbs with swellings and tenderness over both of her femurs. A babygram radiograph revealed multiple fractures, with the presence of callus formation at some fracture sites suggesting intrauterine fractures. The second case is a patient who had normal anthropometry and was well at birth. She was subsequently diagnosed at two weeks of age when she presented to the Chris Hani Baragwanath Academic Hospital with an E. coli meningitis and she was suspected to have a right clavicular fracture and possibly rib fractures as she had pain on palpation over these areas. She was noted to have no blue sclera. Subsequent X-rays confirmed a right clavicular fracture as well as left and right rib fractures at different stages of healing. A lateral skull radiograph revealed Wormian bones. With no available genetic testing in South Africa, both diagnoses were made clinically. Both of our patients were started on zoledronic acid at three months of age and were followed up by the Metabolic Unit at the Chis Hani Baragwanath Academic Hospital. This case report of two patients highlights the characteristics important in diagnosing and treating this uncommon condition with varying phenotypical presentations, thus ensuring that the diagnosis is not missed or misdiagnosed: one disorder, two different faces. 展开更多
关键词 PAEDIATRICS osteogenesis imperfecta Case Report FRACTURES South Africa
下载PDF
Using humeral nail for surgical reconstruction of femur in adolescents with osteogenesis imperfecta 被引量:2
4
作者 Paphon Sa-ngasoongsong Tanyawat Saisongcroh +2 位作者 Chanika Angsanuntsukh Patarawan Woratanarat Pornchai Mulpruek 《World Journal of Orthopedics》 2017年第9期735-740,共6页
Osteogenesis imperfecta(OI) is a rare inherited connective tissue disorder caused by mutation of collagen which results in a wide spectrum of clinical manifestations including long bone fragility fractures and deformi... Osteogenesis imperfecta(OI) is a rare inherited connective tissue disorder caused by mutation of collagen which results in a wide spectrum of clinical manifestations including long bone fragility fractures and deformities. While the treatment for these fractures was recommended as using intramedullary fixation for minimizing stress concentration, the selection of the best implant in the adolescent OI patients for the surgical reconstruction of femur was still problematic, due to anatomy distortion and implant availability. We are reporting the surgical modification by using a humeral nail for femoral fixation in three adolescent OI patients with favorable outcomes. 展开更多
关键词 osteogenesis imperfecta Adolescent HUMERAL NAIL FEMORAL fracture FEMORAL BOWING DEFORMITY
下载PDF
Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfecta 被引量:1
5
作者 Douglas J DiGirolamo Vandana Singhal +2 位作者 Xiaoli Chang Se-Jin Lee Emily L Germain-Lee 《Bone Research》 SCIE CAS CSCD 2015年第1期40-45,共6页
Osteogenesis imperfecta(OI) comprises a group of heritable connective tissue disorders generally defined by recurrent fractures, low bone mass, short stature and skeletal fragility. Beyond the skeletal complications... Osteogenesis imperfecta(OI) comprises a group of heritable connective tissue disorders generally defined by recurrent fractures, low bone mass, short stature and skeletal fragility. Beyond the skeletal complications of OI,many patients also report intolerance to physical activity, fatigue and muscle weakness. Indeed, recent studies have demonstrated that skeletal muscle is also negatively affected by OI, both directly and indirectly. Given the well-established interdependence of bone and skeletal muscle in both physiology and pathophysiology and the observations of skeletal muscle pathology in patients with OI, we investigated the therapeutic potential of simultaneous anabolic targeting of both bone and skeletal muscle using a soluble activin receptor 2B(ACVR2B) in a mouse model of type Ⅲ OI(oim). Treatment of 12-week-old oim mice with ACVR2 B for 4 weeks resulted in significant increases in both bone and muscle that were similar to those observed in healthy,wild-type littermates. This proof of concept study provides encouraging evidence for a holistic approach to treating the deleterious consequences of OI in the musculoskeletal system. 展开更多
关键词 BONE Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfecta
下载PDF
Cell therapy of a patient with type Ⅲ Osteogenesis imperfecta caused by mutation in COL1A2 gene and unstable collagen type I 被引量:1
6
作者 Marcin Majka Magdalena Janeczko +7 位作者 Jolanta Gozdzik Danuta Jarocha Aleksandra Augusciak-Duma Joanna Witecka Marta Lesiak Halina Koryciak-Komarska Aleksander L.Sieron Jacek Jozef Pietrzyk 《Open Journal of Genetics》 2013年第1期49-60,共12页
The allogenic bone marrow derived mesenchymal stem cells transplantation was given to the newborn girl diagnosed with osteogenesis imperfecta type III, with multiple bone fractures, extreme shortness and limbs deformi... The allogenic bone marrow derived mesenchymal stem cells transplantation was given to the newborn girl diagnosed with osteogenesis imperfecta type III, with multiple bone fractures, extreme shortness and limbs deformities. The treatment was performed at the age of 4 and 6 weeks. The clinical diagnosis was supported by biochemical analysis of collagen type I recovered from culture medium of cultivated patient’s skin fibroblast, which revealed its triple helix instability at temperature about 2?C lower than normal. Sequencing of both genes encoding procollagen type I revealed heterozygous substitution G23569Ain COL1A2 gene causing change of glycine at position 517 to aspartate. The donor of mesenchymal stem cells was the girl’s father. She received two intravenous infusions of suspended cultured mesenchymal cells in 16 days apart without any side effects. An analysis of procollagen type I secreted to the culture medium by bone marrow-derived mesenchymal stem cells obtained from the patient, 3 months following transplantation revealed its normal triple helix stability. During the subsequent two years of follow up two new bone fractures were noted. Currently a two-year-old girl’s presents extreme growth and weight deficiency. The motoric development is also retarded, but the patient constantly improves and makes progresses. 展开更多
关键词 Bone Mineralisation Cell Therapy Collagen Type I osteogenesis imperfecta Triple Helix Stability
下载PDF
The Use of Near-Infrared Spectroscopy As a Substitute for Blood Pressure Monitoring in a Patient with Severe Osteogenesis Imperfecta
7
作者 Joshua D. Dilley Edwin J. Abraham Taranjit S. Sangari 《Open Journal of Anesthesiology》 2012年第4期195-197,共3页
The use of near-infrared spectroscopy (NIRS) as a means of assessing regional oxygen supply is a method that has gained recent support and interest. Given the potential of NIRS, this technology was utilized in an infa... The use of near-infrared spectroscopy (NIRS) as a means of assessing regional oxygen supply is a method that has gained recent support and interest. Given the potential of NIRS, this technology was utilized in an infant patient with a case of severe osteogenesis imperfecta that precluded conventional blood pressure monitoring. Using NIRS as a monitor and titrating the anesthetic accordingly produced a good outcome, with no post-operative evidence of detrimental intra-operative hypotension or ischemia. 展开更多
关键词 NEAR INFRARED Spectroscopy osteogenesis imperfecta Monitoring
下载PDF
Radiographic Features of Osteogenesis Imperfecta about a Female Sibship
8
作者 B. M. A. Tiemtore-Kambou A. M. Napon +5 位作者 N.-A. Ndé-Ouédraogo A. Koutou I. F. N. Sieba I. Ouédraogo O. Diallo R. Cissé 《Open Journal of Medical Imaging》 2020年第1期52-61,共10页
Osteogenesis imperfecta (OI) belongs to a group of congenital osteoporosis which hallmark feature is “affecting skeleton, increasing bone fragility that fracture easily and decreasing bone density due to quantitative... Osteogenesis imperfecta (OI) belongs to a group of congenital osteoporosis which hallmark feature is “affecting skeleton, increasing bone fragility that fracture easily and decreasing bone density due to quantitative and/or qualita-tive abnormalities”. We report a female sibling’s involvement in 3 cases with probable recessive inheritance pattern. Only female aged between 5 and 13 years were affected with skeletal lesions in the lower limbs. The boy of this family had no skeletal or extra-skeletal lesions. Their parents had no affection and no bond of consanguinity. The observed malformations can be classified as type V or VI according to Sillence’s clinical classification. Lack of genetic test in our context has limited accuracy of the diagnosis as new data evoke a genetic classification into 12 types that leading an effective therapeutic management. 展开更多
关键词 osteogenesis imperfecta FAMILIAL INVOLVEMENT FEMALE RADIOLOGICAL Features RECESSIVE Mode
下载PDF
Carotid Artery Prolapse and Myringocarotidopexy in Osteogenesis Imperfecta
9
作者 Hassanin Abdulkarim Hassan Haidar +2 位作者 Ahmad Abualsoud Ahmed Elsotouhy A. Salam Alqahtani 《International Journal of Otolaryngology and Head & Neck Surgery》 2015年第4期286-289,共4页
Osteogenesis Imperfecta is a rare genetic disorder of connective tissue that is caused by an error in collagen formation. The disease is characterized by abnormal bone fragility, osteopenia, blue discoloration of the ... Osteogenesis Imperfecta is a rare genetic disorder of connective tissue that is caused by an error in collagen formation. The disease is characterized by abnormal bone fragility, osteopenia, blue discoloration of the sclerae and hearing loss. Chronic non-suppurative otitis media is frequent in Osteogenesis Imperfecta patients and usually attributed to Eustachian tube dysfunction due to cranial molding and deformities. In some cases of severe Osteogenesis Imperfecta, the fragile bone of the petrous carotid canal can be broken down by the pulsations of the carotid artery, this may result in prolapse of the carotid artery into the protympanum with resultant Eustachian tube obstruction and tympanic membrane retraction with adhesion to prolapsed carotid artery, a condition called myringocarotidopexy. 展开更多
关键词 Eustachian Tube CAROTID Artery osteogenesis imperfecta Chronic OTITIS Media Myringocarotidopexy HEARING Loss
下载PDF
Assessment of quality of life in children with osteogenesis imperfecta: a review
10
作者 Yong-Jie Lai Hui-Jia Mao +1 位作者 Yue-Yang Zhang Yi-Bo Wu 《Life Research》 2020年第4期169-175,共7页
Osteogenesis imperfecta is a rare hereditary bone disease which is commonly classified into types I-IV,each of varying severity.The clinical symptoms of the disease consist of increased bone brittleness and recurrent ... Osteogenesis imperfecta is a rare hereditary bone disease which is commonly classified into types I-IV,each of varying severity.The clinical symptoms of the disease consist of increased bone brittleness and recurrent fractures coupled with a variety of complications.The disease damages children’s body functions and restricts their daily activities,thus affects their psychological experience of living conditions and reduces their quality of life.The quality of life of children with osteogenesis imperfecta is primarily assessed through a universal scale and so far there is no osteogenesis imperfecta-specific quality of life scale,which is of great value to the assessment of quality of life.Pain symptoms,related complications,and limitations on physical exercise have been shown to be related to the assessment of quality of life and negatively affect the physical and psychological aspects of quality of life in children with osteogenesis imperfecta.This negative effect is found to be more serious in children diagnosed with severe types of osteogenesis imperfecta.Initial research into bisphosphonate therapy as a treatment for osteogenesis imperfecta has shown promising results in providing a better quality of life,but this treatment needs to be further studied and guided by the assessing results of quality of life.In the future,better methods of assessment and improvement of quality of life for children with osteogenesis imperfecta still rely on the efforts of all sectors of society. 展开更多
关键词 CHILDREN osteogenesis imperfecta Quality of life ASSESSMENT
下载PDF
Health management in children with osteogenesis imperfecta
11
作者 Hai-Jun Li Xi-Zhe He +3 位作者 Qian Du Xiao-Yan Fan Shuxian Xu Yi-Bo Wu 《TMR Aging》 2020年第2期52-58,共7页
Due to the incurable characteristics of osteogenesis imperfecta,health management plays a crucial role for children in healthy growth,independent life and integrating into society.This paper summarizes three dimension... Due to the incurable characteristics of osteogenesis imperfecta,health management plays a crucial role for children in healthy growth,independent life and integrating into society.This paper summarizes three dimensions of "biology-psychology-society",which summarize the research progress for health management in children with osteogenesis imperfecta.In the dimension of biology,the management on diet and complications about children is relatively definite,but more experiments are still needed in order to find out the appropriate values for the using doses of bisphosphonate and treatment time.Additionally,there is a lack of tools to assess the painful degree in children and sports management methods with different types of children with osteogenesis imperfecta nowadays.In the dimension of psychology,it is found that children with osteogenesis imperfecta,their families and carers are all expected to maintain a good state of mind.In the social dimension,we have known the need of children and their families,but their supporting systems are still expected to be improved through practice. 展开更多
关键词 osteogenesis imperfecta CHILDREN Health management
下载PDF
NOVEL SPLICING MUTATION OF COL1A1 GENE CAUSING OSTEOGENESIS IMPERFECTA TYPE I IN CHINESE PEDIGREE
12
作者 吴晓林 顾鸣敏 +5 位作者 崔兵 李西华 陆振虞 王铸钢 袁文涛 宋怀东 《Journal of Shanghai Second Medical University(Foreign Language Edition)》 2007年第1期8-11,共4页
Objective To detect the peculiar mutation in a Chinese family with osteogenesis imperfecta, COL1A1 and COL1A2 being analysed. Methods A genome screen was undertaken covering COL1A1 at 17q21- 22 and COLIA2 at 7q22.1. T... Objective To detect the peculiar mutation in a Chinese family with osteogenesis imperfecta, COL1A1 and COL1A2 being analysed. Methods A genome screen was undertaken covering COL1A1 at 17q21- 22 and COLIA2 at 7q22.1. The Linkage ( Version 5. 1 ) was used for 2-point analysis. DNA sequencing was used to screen and identify the mutation. Results A linkage to the markers on chromosome 17q21-22 was observed. Se- quence analysis of COLIA1 revealed a splicing mutation (IVSS-2A 〉 G) that converted the 3' end of intron 8 from AG to GG. Conclusion This mutation ( IVS 8-2A 〉 G) is novel, and has not yet been registered in the Human Type I and Type Ⅲ Collagen Mutations Database. 展开更多
关键词 COL1A1 gene mutation analysis osteogenesis imperfecta
下载PDF
一个新发SERPINF1基因突变的Ⅵ型成骨发育不全病例家系分析
13
作者 谢泽慧 刘琳 +3 位作者 毛斌 郭亚荣 田琦民 马晓玲 《生殖医学杂志》 CAS 2024年第2期194-200,共7页
Ⅵ型成骨发育不全(OI)是由于SERPINF1基因突变致其编码的色素上皮衍生因子(PEDF)水平低下,从而导致骨矿化不足和矿化时间延长的一种罕见常染色体隐性遗传的单基因遗传病。本文对1例疑似Ⅵ型OI的女性患者及其家系进行了全外显子组基因测... Ⅵ型成骨发育不全(OI)是由于SERPINF1基因突变致其编码的色素上皮衍生因子(PEDF)水平低下,从而导致骨矿化不足和矿化时间延长的一种罕见常染色体隐性遗传的单基因遗传病。本文对1例疑似Ⅵ型OI的女性患者及其家系进行了全外显子组基因测序和家系分析,结果显示患者SERPINF1基因NM_002615.5:c.786G>A(p.Lys262Lys)突变,该突变属于同义突变,符合常染色体隐性遗传模式。分析该致病基因的致病性和保守性后,最终通过辅助生殖技术帮助该患者生育了健康的后代。本研究报道了SERPINF1基因的新突变,丰富了OI的表型,补充了人类SERPINF1基因的突变数据库,为进一步研究Ⅵ型OI的基因型-表型相关性和未来对于此疾病的遗传咨询等提供依据。 展开更多
关键词 成骨发育不全 SERPINF1基因 单基因遗传病 辅助生殖
下载PDF
基于混合研究的成骨不全症患儿生存质量分析
14
作者 杜范艳 莫霖 肖玲 《重庆医科大学学报》 CAS CSCD 北大核心 2024年第2期210-216,共7页
目的:调查西南地区成骨不全症儿童的生存质量现状,分析影响因素,为拟定家庭疾病管理方案提供参考。方法:采用混合研究调查成骨不全症患儿的生存质量。质性研究采用现象学研究,对20名来自某三甲儿童医院的成骨不全症照顾者进行半结构式访... 目的:调查西南地区成骨不全症儿童的生存质量现状,分析影响因素,为拟定家庭疾病管理方案提供参考。方法:采用混合研究调查成骨不全症患儿的生存质量。质性研究采用现象学研究,对20名来自某三甲儿童医院的成骨不全症照顾者进行半结构式访谈,运用Colaizzi 7步分析法对访谈资料进行整理分析。量性研究采用儿童生存质量普适性量表评估西南地区34名成骨不全症患儿的生存质量,并将同龄健康儿童作为对照组;采用单因素及多元线性回归分析确定影响因素。结果:①生存质量主题,担心骨折,疼痛耐受性高,辅助行走器械缺乏,同伴交往减少,学校氛围良好。②成骨不全症患儿生存质量低于健康人群,总分(t=-6.732,P<0.001)、生理功能(P=0.000)和社交维度(P=0.000)差异有统计学意义;多元线性回归显示独立行走能力(t=3.490,P=0.001)和固定玩伴(t=3.164,P=0.003)进入回归方程(P<0.05),共解释生存质量得分变异的40.9%。结论:提升成骨不全症儿童的生存质量需建立家庭疾病管理能力。医务人员需从知识普及、就医指导、未来规划、规避潜在问题等方面建立其慢病管理能力。 展开更多
关键词 儿童 生存质量 混合研究 成骨不全症 疾病家庭管理
下载PDF
成骨不全患儿合并股骨干骨折或畸形的外科治疗与康复
15
作者 李高磊 郑水长 +3 位作者 朱宇 卢文龙 樊晓韩 黎少言 《河南医学研究》 CAS 2024年第1期22-25,共4页
目的探讨并评价儿童成骨不全症外科治疗及康复的临床效果。方法分析2014年6月至2020年6月于郑州大学第二附属医院骨科治疗的成骨不全患儿资料31例,共计51根股骨,其中男18例,女13例,年龄3岁3个月至14岁6个月,平均(124.41±33.13)个月... 目的探讨并评价儿童成骨不全症外科治疗及康复的临床效果。方法分析2014年6月至2020年6月于郑州大学第二附属医院骨科治疗的成骨不全患儿资料31例,共计51根股骨,其中男18例,女13例,年龄3岁3个月至14岁6个月,平均(124.41±33.13)个月,所有患者均行FD可延长髓内钉手术,术后指导康复锻炼,口服钙剂和维生素D制剂,辅助双磷酸盐药物应用,定期随访,术前和术后1.5 a,应用Barthel评分和功能独立评定表(WeeFIM)评估疗效。结果31例患儿均获得随访,除1例患儿二次选用FD可延长髓内钉翻修外,均未发生再骨折情况,Barthel评分由术前(52.10±5.88)分提升为术后(85.16±7.13)分,WeeFIM评分由术前(58.00±13.80)分提升为(83.14±8.16)分,差异有统计学意义(P<0.05)。结论FD延长髓内钉,结合术后抗骨质疏松用药、正规康复功能锻炼,可显著改善成骨不全患儿的日常活动能力,提高生活质量。 展开更多
关键词 成骨不全 可延长髓内钉 康复
下载PDF
骨形态发生蛋白1/tolloid蛋白酶家族在牙及骨组织发育中的作用 被引量:2
16
作者 谢旭东 赵蕾 +1 位作者 吴亚菲 王骏 《华西口腔医学杂志》 CAS CSCD 北大核心 2020年第5期589-593,共5页
骨形态发生蛋白(BMP)1/tolloid(TLD)蛋白酶家族是一类重要的基质金属蛋白酶,可通过调控细胞外基质的生物合成而在组织、器官生长发育中发挥重要作用。临床报道发现BMP1/TLD蛋白酶家族的编码基因发生突变可导致伴有成骨发育不全的Ⅰ型牙... 骨形态发生蛋白(BMP)1/tolloid(TLD)蛋白酶家族是一类重要的基质金属蛋白酶,可通过调控细胞外基质的生物合成而在组织、器官生长发育中发挥重要作用。临床报道发现BMP1/TLD蛋白酶家族的编码基因发生突变可导致伴有成骨发育不全的Ⅰ型牙本质发育不全,提示该蛋白酶家族在牙及骨等硬组织发育中具有重要作用。本文将BMP1/TLD蛋白酶家族在牙和骨组织发育中的作用及其机制所取得的研究进展作一综述。 展开更多
关键词 骨形态发生蛋白1 基因敲除 牙本质发育不全 成骨发育不全 细胞外基质
下载PDF
双膦酸盐治疗26例成骨不全症的疗效分析
17
作者 蔡诗雅 梅亚曌 +1 位作者 章振林 张浩 《中华骨质疏松和骨矿盐疾病杂志》 CSCD 北大核心 2024年第5期419-429,共11页
目的回顾分析使用双膦酸盐(bisphosphonates,BPs)治疗成骨不全症(osteogenesis imperfecta,OI)的疗效并对比不同用药年限、给药途径及起始治疗年龄的疗效差异。方法选取2019年1月至2021年12月就诊于上海交通大学医学院附属第六人民医院... 目的回顾分析使用双膦酸盐(bisphosphonates,BPs)治疗成骨不全症(osteogenesis imperfecta,OI)的疗效并对比不同用药年限、给药途径及起始治疗年龄的疗效差异。方法选取2019年1月至2021年12月就诊于上海交通大学医学院附属第六人民医院骨质疏松和骨病专科接受BPs治疗的26例OI患者,年龄4~67岁,中位年龄12.5岁,其中男17例,女9例。观察治疗前后及治疗过程中骨代谢指标、生化指标、骨密度(bone mineral density,BMD)、脆性骨折发生率等变化。结果26例患者使用阿仑膦酸钠、唑来膦酸或伊班膦酸钠治疗1~5年,给药途径为口服或静脉滴注。用药1年、2~3年及3年以上患者的腰椎BMD分别较基线增加了14.89%、70.73%、64.17%,股骨颈BMD分别增加了12.21%、42.58%、65.28%,全髋BMD分别升高了13.75%、38.95%、94.28%,用药>3年组的股骨颈及全髋BMD增长率显著高于用药1年组(P=0.028、0.002)。不同用药年限患者治疗后脆性骨折次数均下降,且下降幅度(%)及绝对值(次/年)差异无统计学意义(P=0.410、0.459)。口服和静脉用药患者骨钙素(osteocalcin,OC)下降幅度及各部位BMD改善程度相近,且2组患者脆性骨折发生次数均较基线显著减少。未成年组(年龄<18岁)患者治疗结束时腰椎、股骨颈、全髋BMD增加64.64%、45.31%和54.00%,且年均脆性骨折次数较基线减少。成年组(年龄≥18岁)患者治疗结束时骨转换生化标志物(bone turnover biomarkers,BTMs)水平显著下降,腰椎、股骨颈、全髋BMD无显著增加(P=0.393、0.567、0.473),但脆性骨折较基线显著减少(P<0.001)。结论不同用药年限对预防新发脆性骨折疗效相近,用药年限越长,对BMD的改善越显著;口服与静脉用药对新发脆性骨折及BMD的改善疗效相近;未成年OI患者接受BPs可显著增加BMD,未成年及成年患者接受BPs治疗均能预防新发脆性骨折。 展开更多
关键词 成骨不全症 药物治疗 双膦酸盐
下载PDF
Ⅰ型胶原编码基因突变致成骨不全症动物模型
18
作者 姜运怡 张浩 章振林 《中华骨质疏松和骨矿盐疾病杂志》 CSCD 北大核心 2024年第2期168-175,共8页
成骨不全症(osteogenesis Imperfecta,OI)是一类以低骨量、骨脆性及骨骼畸形为特征的单基因遗传性骨病,研究其病理生理学机制和有效治疗方法的关键是动物模型的应用。绝大部分OI由编码Ⅰ型胶原相关基因突变引起,本文总结了COL1A1和COL1A... 成骨不全症(osteogenesis Imperfecta,OI)是一类以低骨量、骨脆性及骨骼畸形为特征的单基因遗传性骨病,研究其病理生理学机制和有效治疗方法的关键是动物模型的应用。绝大部分OI由编码Ⅰ型胶原相关基因突变引起,本文总结了COL1A1和COL1A2突变的主要动物模型,这些模型是研究致病机制、开发和测试新的治疗策略的宝贵工具。未来的研究将运用CRISPR/Cas9等新型基因编辑技术,结合多种生物类别,优化和拓展OI动物模型,更好地模拟人类疾病,有助于对OI及其治疗方法的深入探索。 展开更多
关键词 成骨不全症 动物模型 Ⅰ型胶原 基因突变
下载PDF
成骨不全症干细胞和基因治疗研究进展
19
作者 胡静 沈敏 李梅 《中华骨质疏松和骨矿盐疾病杂志》 CSCD 北大核心 2024年第4期397-402,共6页
成骨不全症(osteogenesis imperfecta,OI)是以骨脆性增加和反复骨折为特征的单基因遗传性骨病。现有药物治疗仅为对症治疗,疗效有限,难以有效改善患者的骨骼质量。干细胞治疗和基因治疗作为靶向OI致病机制的新型治疗策略,具有从病因上... 成骨不全症(osteogenesis imperfecta,OI)是以骨脆性增加和反复骨折为特征的单基因遗传性骨病。现有药物治疗仅为对症治疗,疗效有限,难以有效改善患者的骨骼质量。干细胞治疗和基因治疗作为靶向OI致病机制的新型治疗策略,具有从病因上显著改善疾病预后的潜力。本文综述干细胞治疗和基因治疗OI的基础和临床研究进展,旨在探讨这些治疗策略的应用潜力以及临床转化中的挑战。 展开更多
关键词 成骨不全症 干细胞治疗 间充质干细胞移植 基因治疗
下载PDF
成骨不全症儿童的骨骼表型影像测量研究进展
20
作者 刘家怡 李梅 《中华骨质疏松和骨矿盐疾病杂志》 CSCD 北大核心 2024年第3期266-271,共6页
成骨不全症(osteogenesis imperfecta,OI)是最常见的单基因遗传性骨病,以反复骨折、骨骼畸形和身材矮小为特点。准确定量评估骨骼表型对判断OI严重程度、制定治疗方案和预测预后有重要意义。目前常用OI表型评估方法,如X线检查、双能X射... 成骨不全症(osteogenesis imperfecta,OI)是最常见的单基因遗传性骨病,以反复骨折、骨骼畸形和身材矮小为特点。准确定量评估骨骼表型对判断OI严重程度、制定治疗方案和预测预后有重要意义。目前常用OI表型评估方法,如X线检查、双能X射线吸收测量仪等,难以全面反映骨微结构和骨骼生物力学性能。近年来,多种新型影像测量技术,包括骨小梁评分、高分辨外周骨定量计算机体层成像、磁共振成像等,能够定量评估骨微结构、骨骼生物力学性能,有助于全面了解OI骨骼表型信息、预测骨折风险,值得关注及应用。 展开更多
关键词 成骨不全 骨小梁评分 高分辨外周骨定量计算机体层成像 磁共振成像
下载PDF
上一页 1 2 10 下一页 到第
使用帮助 返回顶部